Detailed answers about KOVIMAN BIOTECHNOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was KOVIMAN BIOTECHNOLOGY LIMITED founded?
KOVIMAN BIOTECHNOLOGY LIMITED was officially incorporated on 3 July 2026 and is registered under company number 17316262. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KOVIMAN BIOTECHNOLOGY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KOVIMAN BIOTECHNOLOGY LIMITED?
KOVIMAN BIOTECHNOLOGY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KOVIMAN BIOTECHNOLOGY LIMITED do?
KOVIMAN BIOTECHNOLOGY LIMITED operates in the following sectors: 21200 - Manufacture of pharmaceutical preparations, 32500 - Manufacture of medical and dental instruments and supplies, 32990 - Other manufacturing n.e.c., 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is KOVIMAN BIOTECHNOLOGY LIMITED's registered address?
The registered office address of KOVIMAN BIOTECHNOLOGY LIMITED is 7 Copperfield Road, Coventry, West Midlands, England, United Kingdom, CV2 4AQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is KOVIMAN BIOTECHNOLOGY LIMITED financially stable?
Financial accounts for KOVIMAN BIOTECHNOLOGY LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.